No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer

International Journal of Cancer

Volumn 125, Issue 9, 2009, Pages 2205-2208

  Otto, Wolfgang ^a   Denzinger, Stefan ^a   Bertz, Simone ^a   Gaumann, Andreas ^a   Wild, Peter J ^b   Hartmann, Arndt ^c   Stoehr, Robert ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Bladder cancer; FGFR3; Normal urothelium

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER RISK; CARCINOGENESIS; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UROTHELIUM; BLADDER; BLADDER TUMOR; CHROMOSOME DELETION; DNA METHYLATION; GENETICS; HETEROZYGOSITY LOSS; METABOLISM; MIDDLE AGED; MUTATION;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; DNA METHYLATION; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 70249105783     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24598     Document Type: Article

References (20)

1. Wun-Lae K, Suk-Chul B. Molecular biomarkers in urothelial bladder cancer. Cancer Sci 2008;99:646-652
2. Zaak D, Karl A, Knüchel R, Stepp H, Hartmann A, Reich O, Bachmann A, Siebels M, Popken G, Stief C. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU Int 2005;96:217-222 (Pubitemid 41097708)
3. Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 2003;169:96-100. (Pubitemid 35461560)
4. Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, Steieck G, Kogevinas M, Real FX, Malats N. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 2007;25:285-295
5. van Rhijn BW, Vis AN, van der Kwast TH, Kirkels WJ, Radvanyi F, Ooms EC, Chopin DK, Boeve ER, Jöbsis AC, Zwarthoff EC. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J Clin Oncol 2003;21:1912-1921 (Pubitemid 46606378)
6. Hernandez S, Lopez-Knowles E, Lloreta J, Kogevinas M, Amoros A, Tardon A, Carrato A, Serra C, Malats N, Real FX. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J Clin Oncol 2006;24:3664-3671 (Pubitemid 46630542)
7. van Oers JM, Wild PJ, Burger M, Denzinger S, Stoehr R, Rosskopf E, Hofstaedter F, Steyerberg EW, Klinkhammer-Schalke M, Zwarthoff EC, van der Kwast TH, Hartmann A. FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Eur Urol 2007;52:760-768 (Pubitemid 47126132)
8. Van Rhijn BW, Montironi R, Zwarthoff EC, Jobsis AC, van der Kwast TH. Frequent FGFR3 mutations in urothelial papilloma. J Pathol 2002;198:245-251 (Pubitemid 35243883)
9. Van Oers JMM, Adam C, Denzinger S, Stoehr R, Bertz S, Zaak D, Stief C, Hofstaedter F, Zwarthoff EC, van der Kwast TH, Knuechel R, Hartmann A. Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder. Int J Cancer 2006;119:1212-1215 (Pubitemid 44116931)
10. Sobin LH, Wittekind C. TNM classification of malignant tumors, 6th edn. New York: Wiley-Liss, 2002.
11. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. World Health Organization, Geneva, No 10, 1973.
12. Stoehr R, Zietz S, Burger M, Filbeck T, Denzinger S, Obermann EC, Hammerschmied C, Wieland WF, Knuechel R, Hartmann A. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. Eur Urol 2005;47:58-63. (Pubitemid 39575719)
13. Dietmaier W, Hartmann A, Wallinger S, Heinmöller E, Kerner T, Endl E, Jauch KW, Hofstädter F, Rüschoff J. Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Pathol 1999;154:83-95. (Pubitemid 29031615)
14. van Oers JM, Lurkin I, van Exsel AJ, Nijsen Y, van Rhijn BW, van der Aa MN, Zwarthoff EC. A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine. Clin Cancer Res 2005;11:7743-7748 (Pubitemid 41611617)
15. Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Hartmann A. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 2006;116:2201-2207 (Pubitemid 44162329)
16. Tomlinson DC, Baldo O, Harnden P, Knowles MA. FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer. J Pathol 2007;213:91-98 (Pubitemid 47354570)
17. Lopez-Beltran A, Alvarez-Kindelan J, Luque R, Blanca A, Quintero A, Montironi R, Cheng L, Gonzalez-Campora R, Requena M. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium. J Pathol 2008;215:263-272 (Pubitemid 351956707)
18. Dhawan D, Hamdy FC, Rehman I, Patterson J, Cross SS, Feeley KM, Stephenson Y, Meuth M, Catto JW. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma. J Pathol 2006;209:336-343 (Pubitemid 43997742)
19. Marsit CJ, Houseman EA, Schned AR, Karagas MR, Kelsey KT. Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. Carcinogenesis 2007;28:1745-1751
20. Zieger K, Dyrskjot L, Wiuf C, Jensen JL, Andersen CL, Jensen KM, Orntoft TF. Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors. Clin Cancer Res 2005;11:7709-7719 (Pubitemid 41611613)